Skip to content

CorMedix CRMD Product sales, net — Total Revenue

Other product segments

DefenCath
$97.51M+150%
Melinta Portfolio
$24.41M
Contract revenue
$5.51M

Similar metrics at other companies

Ardelyx logo
ARDXProduct sales, net — Total revenues
$93.37M+37.7%
Travere Therapeutics, Inc. logo
TVTXTotal net product sales — Total Revenue
$124.49M+64.1%
Esperion Therapeutics logo
ESPRProduct sales, net — Total Revenues
$43.4M+24.3%
Crinetics Pharmaceuticals logo
CRNXProduct revenue, net — Total Revenue
$10.31M
BioCryst Pharmaceuticals logo
BCRXProduct sales, net — Total revenues
$151.4M+5.3%
XER
XERSProduct revenue, net — Product revenue, net
$82.45M+42.6%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's product sales, net — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's product sales, net — total revenue?
CorMedix (CRMD) reported product sales, net — total revenue of $121.92M in Q1 2026.
How has CorMedix's product sales, net — total revenue changed year-over-year?
CorMedix's product sales, net — total revenue increased by 211.9% year-over-year, from $39.08M to $121.92M.
What does product sales, net — total revenue mean?
This metric represents the total revenue generated from the commercial sale of pharmaceutical products after accounting for returns, allowances, and rebates. It serves as a primary indicator of market adoption and commercial success for the company's therapeutic portfolio. Tracking this figure allows investors to evaluate the growth trajectory and revenue-generating capacity of the company's core product offerings.